nach oben

memo - Magazine of European Medical Oncology

Tipp

Neoadjuvant treatment for solid tumors—the earlier, the better

verfasst von: Univ.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Excerpt

Administering adjuvant systemic treatment following local therapy aiming to reduce recurrence rates and mortality is a standard approach in many common malignancies such as breast, colorectal, or lung cancer. Of note, administering systemic treatment already before surgery offers potential additional advantages such as downstaging and downsizing of the primary tumor and regional lymph nodes, in vivo sensitivity testing, earliest possible treatment of potential micrometastatic disease, and response-adapted tailoring of further postoperative therapy. …

Vorheriger Artikel Molecular profiling leading to personalized cancer treatment

Nächster Artikel Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management

Pusch R. Neoadjuvant treatment in solid tumors—the earlier, the better breast cancer. memo. 2022; https://doi.org/10.1007/s12254-022-00819-4. CrossRef

Sonnweber B, Schaber M, Wöll E. Neoadjuvant treatment in gastric cancer. memo. 2022; https://doi.org/10.1007/s12254-022-00823-8. CrossRef

Terbuch A, Absenger G. Neoadjuvant treatment in non-small-cell-lung-cancer—the earlier, the better. memo. 2022; https://doi.org/10.1007/s12254-022-00819-4. CrossRef

Kosma K, Thalhammer S, Grünberger T. Neoadjuvant treatment of pancreatic ductal adenocarcinoma. memo. 2022; https://doi.org/10.1007/s12254-022-00832-7. CrossRef

Titel: Neoadjuvant treatment for solid tumors—the earlier, the better
verfasst von: Univ.-Prof. Dr. Rupert Bartsch
Prof. Dr. Wolfgang Hilbe
Publikationsdatum: 01.09.2022
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-022-00835-4

Home

Zeitschriften

Zeitungen

Podcast

Gesundheitspolitik

Praxis

Leben

Jobs

Fachgebiete

Subfächer Innere Medizin

Fortbildungen

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Neoadjuvant treatment for solid tumors—the earlier, the better

Excerpt

Fachgebiete

Subfächer Innere Medizin

Fortbildungen

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Molecular profiling leading to personalized treatment in breast cancer

Molecular profiling in lung cancer

Publisher Correction: Brain metastases: new systemic treatment approaches

Molecular profiling in colorectal cancer

Multiple myeloma with central nervous system relapse: a case report

Molecular profiling leading to personalized cancer treatment